Funders Fight Re-Identification

Four UK research funding agencies firm up their stance against deliberate attempts by researchers to re-identify supposedly anonymous study participants.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, ADAM NIEMANIn January 2013, Yaniv Erlich from the Whitehead Institute for Biomedical Research in Cambridge, Massachusetts, and his colleagues reported on their ability to correctly identify participants in public sequencing projects like the 1,000 Genomes Project using free, publicly accessible Internet resources.

“The paper is a nice example of how simple it is to re-identify de-identified samples and that the reliance on de-identification as the mechanism of ensuring privacy and avoiding misuse is one that is not viable,” Nita Farahany, a professor of law and research at Duke University in Durham, North Carolina, who was not involved in the study, told The Scientist last year.

And last May, in a preprint posted to arXiv, Harvard University’s Latanya Sweeney—who is now chief technologist at the US Federal Trade Commission—and her colleagues showed that unnamed Personal Genome Project (PGP) participants could be identified using demographic data from their profiles.

Researchers and funders alike have since dedicated significant resources toward protecting study participants’ privacy. This week (March 24), Cancer Research ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Tracy Vence

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio